Thank you very much.
Before I forget, I will cede my last 90 seconds—with your assistance, Mr. Chair—to my colleague Mr. Morrice.
Minister, thank you for being here.
Thank you, distinguished panel of officials, for being here. Thanks for all the work that you're doing.
I just want to note a couple of things first.
The Yukon coroner just announced last week 23 Yukon deaths in 2023 due to substance use. Although that might sound like a fairly small number, that's a range of 50 to 51 deaths per 100,000, again showing how this is affecting smaller and smaller regions and jurisdictions in Canada just as much as anywhere else. It's a toll weighing very heavily on first nations communities as well.
Briefly, on my colleague Dr. Ellis's use of the word “experiment”, I just want to say that, really, the reason for putting in the word “experiment” is that we are trying something new. If we are trying old stuff and doing the same thing over and over again, I think someone much smarter than me called that the definition of insanity. An experiment is really determining the efficacy or likelihood of something previously untried. I think that is the idea behind new models, such as decriminalization in B.C. linked with safe supply, harm reduction and the other pillars of care.
If there is a failed experiment, surely it's prohibition. I'm not sure of a single example of prohibition actually working. I would also say that if we go to a purely recovery-based model and discourage the other pillars, as some jurisdictions are trying, then we are getting toward approaches that are based solely on values rather than public health evidence.
In view of my time, Minister Saks, I do want to give you a chance to answer a question. This is around the new substance use strategy that was published, along with the funding. I think it was $359 million in budget 2023.
I want to know a little bit—perhaps in a minute or less—about your discussions with provinces and territories and about how you see building consensus towards approaches that make the best use of this money, the $359 million over five years, and the controlled substance strategy.